India, Aug. 13 -- A Delhi court on Monday denied anticipatory bail to a man accused of supplying fake Ozempic medicines to several foreign companies, observing that such instances threaten the reputation of India's pharmaceutical industry and endanger public health.

Ozempic is used to cure Type-2 Diabetes and is an anti-obesity medication used for long-term weight management.

The order was passed by additional sessions judge Saurabh Partap Singh Laler of Patiala House Court. The court was deciding on an anticipatory bail plea moved by Vicky Ramancha, who has been accused of criminal conspiracy and cheating a foreign firm by supplying them counterfeit pharmaceutical drugs, specifically Ozempic.

A case was lodged against Ramancha by the ...